Tech Company Financing Transactions
Terremoto Biosciences Funding Round
On 4/15/2026, Terremoto Biosciences received $108 million in Series C funding from Cormorant Asset Management, Deep Track Capital and Novo Holdings.
Transaction Overview
Company Name
Announced On
4/15/2026
Transaction Type
Venture Equity
Amount
$108,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1700 Owens St
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
The world has witnessed incredible advances in drug development over the last two decades, including new drugs for previously intractable targets. And yet, many patients still face too few treatment options, notably in devastating conditions like cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Thompson
Browse more venture capital transactions:
Prev: 4/15/2026: Upstage venture capital transaction
Next: 4/15/2026: Contoro Robotics venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs